Symbicort and Advair are similar brand-name prescription medications that treat asthma and COPD. They contain slightly different active ingredients. Symbicort and Advair are two drugs that treat ...

It's a minor mystery in the drug world that's become a topic of debate among AstraZeneca (AZN)'s Symbicort sales staff: Why, in TV commercials for the asthma drug, is the presenter represented as a ...

The price you pay for Symbicort may depend on factors such as your dosage, whether you have health insurance, and the pharmacy you use. You may be able to lower your long-term costs by getting a ...

AstraZeneca’s aging respiratory giant Symbicort won a coveted pediatric exclusivity nod from the FDA on Wednesday, giving the brand a longer life—and potentially hundreds of millions in additional ...

(RTTNews) - The U.S. Food and Drug Administration approved Mylan Pharmaceuticals, Inc.'s generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol. It is the first FDA- ...

AstraZeneca’s Don Apruzzese, formerly senior director of consumer marketing, is moving over to become regional commercial leader on the Symbicort for asthma launch, scheduled for mid-2007. In a world ...

Iconovo, which develops complete inhalation products for a global market, is expanding its collaboration with Amneal for Symbicort in the ICOres inhaler to include additional territories with a ...

The SMART (Symbicort Maintenance and Reliever Therapy) approach allows patients to increase the dose of Symbicort (a combination of an inhaled corticosteroid and long-acting bronchodilator) during ...

AstraZeneca Announces Symbicort Is Now Available In The U.S. U.S. Asthma Sufferers Now Have a New Choice of Combination Therapy to Help Achieve Asthma Control LONDON ...

Harvard Pilgrim Health Care has entered into its third outcomes-based pharmaceutical contract tying what it pays for drugs to how well the patient does on the medicine. In its most recent agreement, ...

LargePharma_SymbicortAstraZeneca’s Symbicort, the second-to-market ICS/LABA combo behind GlaxoSmithKline’s Advair, faced an uphill battle on its launch in June 2007, squaring off against a firmly ...